Rankings
▼
Calendar
LIVN Q2 2016 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena
LIVN
LivaNova PLC
$3B
Q2 2016 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$321M
Gross Profit
$190M
59.3% margin
Operating Income
$22M
6.9% margin
Net Income
$9M
2.8% margin
EPS (Diluted)
$0.18
QoQ Revenue Growth
+11.8%
Cash Flow
Operating Cash Flow
$3M
Free Cash Flow
-$5M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$2.5B
Total Liabilities
$701M
Stockholders' Equity
$1.8B
Cash & Equivalents
$64M
Revenue Segments
Cardiac Surgery
$161M
50%
Neuromodulation
$90M
28%
Cardiac Rhythm Management
$70M
22%
Geographic Segments
UNITED STATES
$124M
35%
Europe
$111M
31%
Non-U.S. and Europe
$86M
24%
FRANCE
$34M
10%
← FY 2016
All Quarters
Q3 2016 →
